March 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alkami Technology, Intel and Wells Fargo & Co, on Thursday.
HIGHLIGHTS
* Alkami Technology Inc ALKT.O: Stephens raises to overweight from equal-weight |
* Cloudflare NET.N: RBC cuts target price to $148 from $170 |
* Intel INTC.O: BofA Global Research raises to neutral from underperform |
* Wells Fargo & Co WFC.N: RBC raises to outperform from sector perform |
* Williams-Sonoma, Inc. WSM.N: Barclays raises target price to $131 from $123 |
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
* 89Bio Inc ETNB.O: Citigroup initiates coverage with buy rating; price target $25 |
* Adobe Inc ADBE.O: Baird cuts target price to $490 from $500 |
* Adobe Inc ADBE.O: BMO cuts target price to $495 from $515 |
* Adobe Inc ADBE.O: BofA Global Research cuts price objective to $528 from $605 |
* Adobe Inc ADBE.O: D.A. Davidson cuts target price to $600 from $625 |
* Adobe Inc ADBE.O: HSBC cuts target price to $475 from $510 |
* Adobe Inc ADBE.O: JP Morgan cuts target price to $540 from $580 |
* Adobe Inc ADBE.O: Mizuho cuts target price to $575 from $620 |
* Adobe Inc ADBE.O: Morgan Stanley cuts target price to $600 from $660 |
* Adobe Inc ADBE.O: Oppenheimer cuts target price to $530 from $560 |
* Adobe Inc ADBE.O: RBC cuts target price to $530 from $550 |
* Adobe Inc ADBE.O: Stifel cuts target price to $525 from $600 |
* Adobe Inc ADBE.O: TD Cowen cuts target price to $490 from $550 |
* Adobe Systems ADBE.O: Morgan Stanley cuts target price to $600.00 from $660.00 |
* Adobe Inc ADBE.O: Oppenheimer cuts target price to $530 from $560 |
* AIG AIG.N: BMO raises target price to $83 from $75 |
* Albertsons Companies Inc ACI.N: RBC raises target price to $23 from $22 |
* Alkami Technology Inc ALKT.O: Stephens raises to overweight from equal-weight |
* American Eagle Outfitters Inc AEO.N: Barclays cuts target price to $10 from $17 |
* American Eagle Outfitters Inc AEO.N: Barclays cuts to underweight from equal weight |
* American Eagle Outfitters Inc AEO.N: BMO cuts target price to $15 from $19 |
* American Eagle Outfitters Inc AEO.N: JP Morgan cuts target price to $15 from $19 |
* American Eagle Outfitters Inc AEO.N: Morgan Stanley cuts target to $12.00 from $16.00 |
* American Eagle Outfitters Inc AEO.N: TD Cowen cuts target price to $11 from $16 |
* American Homes 4 Rent AMH.N: Mizuho cuts target price to $37 from $41 |
* American Water Works Company, Inc. AWK.N: Wells Fargo raises target to $142 from $133 |
* Apogee Therapeutics Inc APGE.O: Citigroup initiates coverage with buy rating; PT $95 |
* Arcbest Corp ARCB.O: Truist Securities initiates coverage with buy rating; PT $93 |
* Ardent Health Partners Inc ARDT.N: JP Morgan cuts target price to $18 from $20 |
* Arvinas Inc ARVN.O: Guggenheim cuts target price to $32 from $57 |
* Avidity Biosciences Inc RNA.O: Citigroup initiates coverage with buy rating; PT $70 |
* Beam Therapeutics Inc BEAM.O: Citigroup raises target price to $64 from $56 |
* Beauty Health Co SKIN.O: Canaccord Genuity cuts target price to $1.50 from $1.75 |
* Biote Corp BTMD.O: Truist Securities cuts target price to $7 from $9 |
* Block Inc XYZ.N: Citigroup cuts target price to $90 from $108 |
* Cadre Holdings Inc CDRE.N: Jefferies cuts target price to $40 from $44 |
* Caretrust Reit Inc CTRE.N: Deutsche Bank raises target price to $31 from $27 |
* Caretrust Reit Inc CTRE.N: Deutsche Bank raises to buy from hold |
* Cervomed Inc CRVO.O: Jonestrading raises to buy from hold |
* CH Robinson Worldwide Inc CHRW.O: Truist Securities initiates coverage with buy rating |
* CH Robinson Worldwide Inc CHRW.O: Truist Securities initiates coverage with PT $115 |
* Cloudflare NET.N: Mizuho cuts target price to $140 from $160 |
* Cloudflare NET.N: Needham cuts target price to $145 from $185 |
* Cloudflare NET.N: Piper Sandler cuts target price to $131 from $153 |
* Cloudflare NET.N: RBC cuts target price to $148 from $170 |
* Consolidated Edison Inc ED.N: Jefferies raises target price to $113 from $108 |
* Contineum Therapeutics Inc CTNM.O: Jonestrading initiates coverage with buy rating |
* Contineum Therapeutics Inc CTNM.O: Jonestrading initiates coverage with PT $23 |
* Corteva CTVA.N: Berenberg raises target price to $59 from $57 |
* Crescent Energy Co CRGY.N: Raymond James cuts target price to $18 from $23 |
* Dentsply Sirona Inc XRAY.O: Mizuho cuts target price to $18 from $21 |
* Dentsply Sirona Inc XRAY.O: Needham cuts to hold rating |
* E W Scripps Co SSP.O: Benchmark raises target price to $8 from $7 |
* EOG Resources, Inc. EOG.N: Wells Fargo cuts target price to $146 from $150 |
* Exelixis Inc EXEL.O: RBC raises target price to $40 from $38 |
* Expeditors International of Washington EXPD.N: Truist Securities initiates with hold rating |
* Expeditors International of Washington EXPD.N: Truist Securities initiates with PT $110 |
* Federal Realty Investment Trust FRT.N: Truist Securities cuts target to $105 from $114 |
* Federal Realty Investment Trust FRT.N: Truist Securities cuts target to hold from buy |
* Fedex Corp FDX.N: Truist Securities initiates coverage with buy rating; PT $305 |
* GXO Logistics Inc GXO.N: Truist Securities initiates coverage with hold rating; PT $40 |
* Heritage Insurance Holdings Inc HRTG.N: Truist Securities raises PT to $20 from $15 |
* Huntington Bancshares Inc HBAN.O: Citigroup cuts target price to $20 from $21 |
* Intel INTC.O: BofA Global Research raises target price to $25 from $19 |
* Intel INTC.O: BofA Global Research raises to neutral from underperform |
* Invitation Homes Inc INVH.N: Mizuho raises target price to $36 from $33 |
* Invitation Homes Inc INVH.N: Mizuho raises to outperform from neutral |
* Ionis Pharmaceuticals Inc IONS.O: Leerink Partners raises target price to $55 from $52 |
* J B Hunt Transport Services Inc JBHT.O: Truist Securities initiates with hold rating |
* J B Hunt Transport Services Inc JBHT.O: Truist Securities initiates with PT $165 |
* Kinetik Holdings Inc KNTK.N: RBC cuts target price to $63 from $67 |
* Kontoor Brands, Inc. KTB.N: Wells Fargo cuts target price to $90 from $100 |
* Kymera Therapeutics Inc KYMR.O: Citigroup initiates coverage with buy rating; PT $52 |
* Landstar System Inc LSTR.O: Truist Securities initiates coverage with hold rating |
* Landstar System Inc LSTR.O: Truist Securities initiates coverage with price target $160 |
* LGI Homes Inc LGIH.O: JP Morgan cuts target price to $65 from $80 |
* McCormick MKC.N: Deutsche Bank raises target price to $82 from $81 |
* Mercury Systems Inc MRCY.O: Truist Securities raises target price to $56 from $49 |
* Mercury Systems Inc MRCY.O: Truist Securities raises to buy from hold |
* Micron Technology, Inc. MU.O: Wells Fargo cuts target price to $130 from $140 |
* Microsoft MSFT.O: D.A. Davidson raises to buy from neutral; raises PT to $450 from $425 |
* Mister Car Wash Inc MCW.O: Raymond James initiates coverage with outperform rating |
* Mister Car Wash Inc MCW.O: Raymond James initiates coverage with target price $10 |
* Moderna MRNA.O: Citigroup initiates coverage with neutral rating; price target $40 |
* Nike Inc. NKE.N: Morgan Stanley cuts target price to $72.00 from $74.00 |
* Old Dominion Freight Line Inc ODFL.O: Truist Securities initiates with buy rating |
* Old Dominion Freight Line Inc ODFL.O: Truist Securities initiates with price target $220 |
* Oscar Health Inc OSCR.N: Wells Fargo cuts target price to $16 from $20 |
* Oscar Health Inc OSCR.N: Wells Fargo cuts to equal weight from overweight |
* Paychex Inc PAYX.O: TD Cowen raises target price to $147 from $146 |
* PBF Energy Inc. PBF.N: Wells Fargo cuts target price to $22 from $25 |
* Perspective Therapeutics, Inc. CATX.A: H.C. Wainwright initiates coverage with buy rating |
* Perspective Therapeutics, Inc. CATX.A: H.C. Wainwright initiates coverage with PT $10 |
* Phreesia Inc PHR.N: Canaccord Genuity raises target price to $35 from $34 |
* Planet Fitness Inc PLNT.N: Canaccord Genuity initiates coverage with buy rating |
* Planet Fitness Inc PLNT.N: Canaccord Genuity initiates coverage with price target $120 |
* PTC Therapeutics Inc PTCT.O: Citigroup raises target price to $50 from $46 |
* RXO Inc RXO.N: Truist Securities initiates coverage with buy rating; price target $24 |
* Sentinelone Inc S.N: BofA Global Research cuts target price to $24 from $29 |
* Sentinelone Inc S.N: Canaccord Genuity cuts target price to $26 from $30 |
* Sentinelone Inc S.N: Guggenheim cuts target price to $28 from $31 |
* Sentinelone Inc S.N: Jefferies cuts target price to $25 from $30 |
* Sentinelone Inc S.N: Needham cuts target price to $23 from $32 |
* Sentinelone Inc S.N: Piper Sandler cuts target price to $28 from $32 |
* Sentinelone Inc S.N: Raymond James cuts target price to $25 from $30 |
* Sentinelone Inc S.N: Scotiabank cuts target price to $19 from $26 |
* Sentinelone Inc S.N: TD Cowen cuts target price to $26 from $35 |
* Sentinelone Inc S.N: Wells Fargo cuts target price to $22 from $30 |
* Smith Douglas Homes Corp SDHC.N: RBC cuts target price to $21 from $25 |
* Smith Douglas Homes Corp SDHC.N: Wells Fargo cuts target price to $21 from $24 |
* Southern Copper Corp SCCO.N: UBS raises to buy from neutral |
* Sprinklr Inc CXM.N: JP Morgan cuts target price to $10 from $11 |
* Sprinklr Inc CXM.N: Rosenblatt Securities raises target price to $12 from $10.50 |
* Sprinklr Inc CXM.N: Scotiabank raises target price to $9 from $8.5 |
* Superior Group of Companies Inc SGC.O: Barrington Research cuts target to $18 from $21 |
* Teradyne Inc TER.O: Citigroup cuts target price to $100 from $130 |
* Tronox Holdings Plc TROX.N: Mizuho cuts target price to $9 from $11 |
* Txnm Energy Inc TXNM.N: Jefferies raises target price to $58 from $53 |
* Uipath Inc PATH.N: BofA Global Research cuts underperform from neutral |
* Uipath Inc PATH.N: BofA Global Research cuts price objective to $10 from $18 |
* Uipath Inc PATH.N: Canaccord Genuity cuts target price to $14 from $19 |
* Uipath Inc PATH.N: JP Morgan cuts target price to $15 from $18 |
* Uipath Inc PATH.N: Mizuho cuts target price to $12 from $14 |
* Uipath Inc PATH.N: Morgan Stanley cuts target price to $12.00 from $16.00 |
* Uipath Inc PATH.N: RBC cuts target price to $13 from $16 |
* Uipath Inc PATH.N: Scotiabank cuts target price to $12 from $15 |
* Uipath Inc PATH.N: Truist Securities cuts target price to $12 from $14 |
* Uipath Inc PATH.N: Wells Fargo cuts target price to $11 from $13 |
* UPS UPS.N: Truist Securities initiates coverage with buy rating; price target $140 |
* Vital Farms Inc VITL.O: D.A. Davidson cuts target price to $42 from $44 |
* Vitesse Energy Inc VTS.N: Alliance Global Partners cuts target price to $26 from $29 |
* Vivid Seats Inc SEAT.O: Benchmark cuts target price to $6 from $8 |
* Vivid Seats Inc SEAT.O: BofA Global Research cuts underperform from buy |
* Vivid Seats Inc SEAT.O: BofA Global Research cuts price objective to $2.6 from $6.25 |
* Vivid Seats Inc SEAT.O: Morgan Stanley cuts target price to $3.75 from $4.60 |
* Vivid Seats Inc SEAT.O: Raymond James cuts to market perform from outperform |
* Voyager Therapeutics Inc VYGR.O: Citigroup cuts target price to $11 from $12 |
* Wells Fargo & Co WFC.N: RBC raises to outperform from sector perform |
* Williams-Sonoma, Inc. WSM.N: Barclays raises target price to $131 from $123 |
* XPO Inc XPO.N: Truist Securities initiates coverage with buy rating; price target $130 |
* Zevra Therapeutics Inc ZVRA.O: Guggenheim raises target price to $22 from $21 |
* Zimvie Inc ZIMV.O: Needham cuts to hold rating |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.